77 editable inputs. Two-ramp cohort simulation (center rollout x per-center consult ramp) recalculates all 60 months live.
Monthly revenue, expenditure, cashflows, IRR, MIRR, max cash required, and payback period.
Per-center per-episode economics: doctor cost, nurse cost, lab, medicine, gross margin, net profit.
13 chronic + 3 NSAID + 3 antibiotic medicines. 6 lab tests with configurable market prices and frequencies.
Complete the form below to access the ZoyeMed financial model. All sessions are logged.
Disclaimer: This financial model is provided strictly for illustrative and assessment purposes only and does not constitute an offer, invitation, or solicitation for investment. All projections are based on variable assumptions. Prospective business partners must rely on their own independent evaluation and due diligence before making any decisions.
Enter pack size (pills), market price (USD/pack), and pills per prescription. Price/Rx is derived.
| Medicine | Pills/Pack | Price/Pack | Pills/Rx | Price/Rx |
|---|---|---|---|---|
| AVG CHRONIC | — | |||
| Medicine | Pills/Pack | Price/Pack | Pills/Rx | Price/Rx |
|---|---|---|---|---|
| AVG NSAIDs | — | |||
| Medicine | Pills/Pack | Price/Pack | Pills/Rx | Price/Rx |
|---|---|---|---|---|
| AVG ANTIBIOTICS | — | |||
| OVERALL MEDICINE AVG (D55) | — | |||
Market price per test and frequency per 100 patients. Weighted average auto-calculates.
| Test | Market Price | Freq/100 pts | Weighted |
|---|---|---|---|
| WEIGHTED AVG (D64) | — |
| Line Item | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|
| Month | New Ctrs | Cum Ctrs | Consults | Revenue | Expenditure | Investment | Net CF | Cum CF |
|---|